Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target

被引：114

作者：

Krystof, Vladimir ^{[1
,2
]}

Baumli, Sonja ^{[3
]}

Fuerst, Robert ^{[4
]}

机构：

[1] Palacky Univ, Lab Growth Regulators, Fac Sci, Olomouc 78371, Czech Republic

[2] Inst Expt Bot ASCR, Olomouc 78371, Czech Republic

[3] Univ Newcastle, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England

[4] Univ Munich, Dept Pharm, Ctr Drug Res Pharmaceut Biol, D-81377 Munich, Germany

来源：

CURRENT PHARMACEUTICAL DESIGN | 2012年 / 18卷 / 20期

基金：

英国医学研究理事会;

关键词：

Cancer; inflammation; kinase; P-TEFb; inhibitor; therapeutics; angiogenesis; FLAVOPIRIDOL INDUCES APOPTOSIS; GROWTH-FACTOR EXPRESSION; MULTIPLE-MYELOMA CELLS; P-TEFB; TRANSCRIPTION ELONGATION; KAPPA-B; DOWN-REGULATION; CDK9/CYCLIN T1; SELICICLIB CYC202; CRYSTAL-STRUCTURE;

D O I：

10.2174/138161212800672750

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Deregulation of cyclin-dependent kinases (CDKs) has been associated with many cancer types and has evoked an interest in chemical inhibitors with possible therapeutic benefit. While most known inhibitors display broad selectivity towards multiple CDKs, recent work highlights CDK9 as the critical target responsible for the anticancer activity of clinically evaluated drugs. In this review, we discuss recent findings provided by structural biologists that may allow further development of highly specific inhibitors of CDK9 towards applications in cancer therapy. We also highlight the role of CDK9 in inflammatory processes and diseases.

引用

页码：2883 / 2890

页数：8

共 50 条

[31] CDK9 inhibitors in acute myeloid leukemia [J].

Boffo, Silvia ;

Damato, Angela ;

Alfano, Luigi ;

Giordano, Antonio .

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37

[32] Cyclin-Dependent Kinase 9 Activity Regulates Neutrophil Spontaneous Apoptosis [J].

Wang, Keqing ;

Hampson, Peter ;

Hazeldine, Jon ;

Krystof, Vladimir ;

Strnad, Miroslav ;

Pechan, Paul ;

Lord, Janet M. .

PLOS ONE, 2012, 7 (01)

[33] Targeting cyclin-dependent kinase 9 sensitizes medulloblastoma cells to chemotherapy [J].

Song, Heyu ;

Bhakat, Reeyan ;

Kling, Matthew J. ;

Coulter, Donald W. ;

Chaturvedi, Nagendra K. ;

Ray, Sutapa ;

Joshi, Shantaram S. .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 520 (02) :250-256

[34] Cyclin-dependent Kinase 9 as a Potential Target for Anti-TNF-resistant Inflammatory Bowel Disease [J].

Omer, Omer S. ;

Hertweck, Arnulf ;

Roberts, Luke B. ;

Lo, Jonathan W. ;

Clough, Jennie N. ;

Jackson, Ian ;

Pantazi, Eirini D. ;

Irving, Peter M. ;

MacDonald, Tom T. ;

Pavlidis, Polychronis ;

Jenner, Richard G. ;

Lord, Graham M. .

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2022, 14 (03) :625-641

[35] Bifunctional degraders of cyclin dependent kinase 9 (CDK9): Probing the relationship between linker length, properties, and selective protein degradation [J].

Tokarski, Robert J. ;

Sharpe, Chia M. ;

Huntsman, Andrew C. ;

Mize, Brittney K. ;

Ayinde, Oluwatosin R. ;

Stahl, Emily H. ;

Lerma, James R. ;

Reed, Andrew ;

Carmichael, Bridget ;

Muthusamy, Natarajan ;

Byrd, John C. ;

Fuchs, James R. .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 254

[36] Synthesis and biological evaluation of N9-cis-cyclobutylpurine derivatives for use as cyclin-dependent kinase (CDK) inhibitors [J].

Park, Sun Jun ;

Kim, Eunjin ;

Yoo, Miyoun ;

Lee, Joo-Youn ;

Park, Chi Hoon ;

Hwang, Jong Yeon ;

Du Ha, Jae .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (18) :4399-4404

[37] Targeting CDK9 for the Treatment of Glioblastoma [J].

Ranjan, Alice ;

Pang, Ying ;

Butler, Madison ;

Merchant, Mythili ;

Kim, Olga ;

Yu, Guangyang ;

Su, Yu-Ting ;

Gilbert, Mark R. ;

Levens, David ;

Wu, Jing .

CANCERS, 2021, 13 (12)

[38] First in Human (FIH) Study of GFH009, a Highly Selective Cyclin-Dependent Kinase 9 (CDK9) Inhibitor, in Patients with Relapsed/Refractory (r/r) Hematologic Malignancies [J].

Qi, Junyuan ;

Zhou, Keshu ;

Qian, Wenbin ;

Zang, Aimin ;

Kadia, Tapan M. ;

Lipsky, Andrew H. ;

Yang, Yanli ;

Wang, Yu ;

Shen, Haige ;

Zheng, Bo ;

Zheng, Chanli ;

Cicic, Dragan ;

Wang, Jianxiang .

BLOOD, 2022, 140 :9473-9474

[39] Identification of a novel CDK9 inhibitor targeting the intramolecular hidden cavity of CDK9 induced by Tat binding [J].

Asamitsu, Kaori ;

Hirokawa, Takatsugu ;

Okamoto, Takashi .

PLOS ONE, 2022, 17 (11)

[40] CDK9: A key player in cancer and other diseases [J].

Carolina Franco, Lia ;

Morales, Fatima ;

Boffo, Silvia ;

Giordano, Antonio .

JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (02) :1273-1284

← 1 2 3 4 5 →